Identification of Markers on the Basis of Transcriptomic Analysis for Molecular Assignment of Medulloblastoma
International Journal of Molecular Sciences · 24.06.2026 · 27 (13) · 5720
DOI: 10.3390/ijms27135720 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 24.06.2026. Verfasst von Sergio Juárez-Méndez und 15 weiteren Autor:innen. Beteiligte Einrichtung: Experimental Oncology Laboratory, National Institute of Pediatrics, Mexico City 04530, Mexico. Hauptthemen laut MEDLINE: Medulloblastoma, Gene Expression Profiling, Biomarkers, Tumor, Cerebellar Neoplasms. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Secretaria de Salud, Ministry of Sciences, Humanities, Technology and Innovation.
Abstract (Originalsprache)
Medulloblastoma is a heterogeneous solid tumor, and its molecular characteristics are the most important prognostic factors for this neoplasm. Unfortunately, the molecular classification of MB-G3 and MB-G-4 medulloblastoma is very complex because of molecular similarity. Therefore, in this work, through unsupervised machine learning-based gene expression profiling, we identified a low molecular profile associated with four molecular groups of medulloblastoma. We performed medulloblastoma expression microarray data mining via the Partek Genomics Suite and Transcriptome Analysis Console (TAC), and we included a total of 25 fresh medulloblastoma tumors that were obtained and hybridized into HG U133 Plus 2.0 Array microarrays. To identify the molecular groups of the 25 patients, we compared them against classified patients, which were obtained from free repositories, and through data mining based on gene expression, compared the expression profiles of our patients. To do so, we performed an analysis via the least squares method via PCA. The molecular groups MB-WNT and MB-SHH were confirmed via immunohistochemistry via β-catenin, YAP1 and GAB1 antibodies in tissue fixed in formalin and embedded in paraffin, and another tissue section was placed on a Visium Spatial slide to perform spatial RNA-seq via Illumina NextSeq 2000 platform sequencers. The data obtained were analyzed with R. We identified the expression profiles associated with the four molecular groups and formed a reference set. Through unsupervised analysis via the least squares method, we assigned the molecular profiles of 25 patients with medulloblastoma, via the integration of bulk and spatial tumor molecular gene expression profiling analysis and with immunohistochemical findings, this strategy was fast and accurate. We observed correlations in three of the trials carried out and, in part, in one study, a patient who presented two tumor strains and two molecular signatures (SHH and G4), which led us to believe that this patient presented mixed phenotypic characteristics. Multigene expression profile analysis of medulloblastoma represents a significant advance in precision medicine; integrating different layers of transcriptomic information allows us to demonstrate underlying molecular changes in the four molecular groups that are essential for personalized therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Experimental Oncology Laboratory, National Institute of Pediatrics, Mexico City 04530, Mexico.
- Molecular Pathology Laboratory, Department of Pathology, National Institute of Pediatrics, Mexico City 04530, Mexico.
- Human Systems Biology Laboratory, National Institute of Genomic Medicine, Mexico City 14610, Mexico.
- Postgraduate in Biological Sciences, Postgraduate Unit, Building D, 1st Floor, Postgraduate Circuit, University City, Coyoacán, Mexico City 04510, Mexico.
- Department of Pediatric Oncology, National Institute of Pediatrics, Mexico City 04530, Mexico.
- Department of Pathology, National Institute of Pediatrics, Mexico City 04530, Mexico.
ORCID-Profile: Sergio Juárez-Méndez, Vanessa Villegas-Ruíz, Edgar Krötzsch, Miguel Rodríguez-Morales, Mario Perezpeña-Diazconti, Pilar Eguía-Aguilar, Osbaldo Resendis-Antonio, Jorge Melendez-Zajgla
Förderung
- Secretaria de Salud
- Ministry of Sciences, Humanities, Technology and Innovation
Zitieren
APA
Juárez-Méndez, S., Vázquez-Jiménez, A., Ramírez-Chiquito, J. C., Villegas-Ruíz, V., Niembro-Zuñiga, A. M., Farfán-Morales, J. E., Marhx-Bracho, A., Krötzsch, E., Rodríguez-Morales, M., Segura-Solís, E., Perezpeña-Diazconti, M., Ridaura-Sanz, C., Rivera-Luna, R., Eguía-Aguilar, P., Resendis-Antonio, O., & Melendez-Zajgla, J. (2026). Identification of Markers on the Basis of Transcriptomic Analysis for Molecular Assignment of Medulloblastoma. International Journal of Molecular Sciences, 27(13), 5720. https://doi.org/10.3390/ijms27135720
Vancouver
Juárez-Méndez S, Vázquez-Jiménez A, Ramírez-Chiquito JC, Villegas-Ruíz V, Niembro-Zuñiga AM, Farfán-Morales JE, et al. Identification of Markers on the Basis of Transcriptomic Analysis for Molecular Assignment of Medulloblastoma. International Journal of Molecular Sciences. 2026;27(13):5720. doi:10.3390/ijms27135720
BibTeX
@article{JurezMndez2026,
author = {Juárez-Méndez, Sergio and Vázquez-Jiménez, Aarón and Ramírez-Chiquito, Josselen Carina and Villegas-Ruíz, Vanessa and Niembro-Zuñiga, Ana Maria and Farfán-Morales, José Eduardo and Marhx-Bracho, Alfonso and Krötzsch, Edgar and Rodríguez-Morales, Miguel and Segura-Solís, Emma and Perezpeña-Diazconti, Mario and Ridaura-Sanz, Cecilia and Rivera-Luna, Roberto and Eguía-Aguilar, Pilar and Resendis-Antonio, Osbaldo and Melendez-Zajgla, Jorge},
title = {Identification of Markers on the Basis of Transcriptomic Analysis for Molecular Assignment of Medulloblastoma},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {13},
pages = {5720},
doi = {10.3390/ijms27135720}
}
EUVIMED